2. Academic Validation
  3. Unintended consequences--the cost of preventing preterm births after FDA approval of a branded version of 17OHP

Unintended consequences--the cost of preventing preterm births after FDA approval of a branded version of 17OHP

  • N Engl J Med. 2011 May 5;364(18):1689-91. doi: 10.1056/NEJMp1102796.
Joanne Armstrong 1
Affiliations

Affiliation

  • 1 Women's Health Division, Aetna, Sugar Land, TX, USA.
PMID: 21410391 DOI: 10.1056/NEJMp1102796
Figures
Products